Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-22-053827

EVP, Drug Development gave up 2,012 shares (to pay taxes)

  • EVP, Drug Development acquired 5,814 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
MANHARD KIMBERLY EVP, Drug Development 2022-10-13 Option exercise +1,250 15,924 D: show line 1 in the form
MANHARD KIMBERLY EVP, Drug Development 2022-10-13 Option exercise +4,564 20,488 D: show line 2 in the form
MANHARD KIMBERLY EVP, Drug Development 2022-10-13 Shares withheld for taxes −2,012 $3.76 $7,565 18,476 D: show line 3 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
MANHARD KIMBERLY EVP, Drug Development 2022-10-13 Option exercise · Restricted Stock Units −1,250 10,000 D: show line 4 in the form
MANHARD KIMBERLY EVP, Drug Development 2022-10-13 Option exercise · Restricted Stock Units −4,564 37,064 D: show line 5 in the form
Loading xslF345X03/doc4.xml…